Codexis Inc

NASDAQ: CDXS
$4.32
-$0.01 (-0.2%)
Closing Price on November 21, 2024

CDXS Stock Chart and Intraday Price

CDXS Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry INDUSTRIAL ORGANIC CHEMICALS
Address 200 PENOBSCOT DRIVE, REDWOOD CITY, CA, US
Fiscal Year End December
Latest Quarter 9/30/2023
Market Cap 324.10M USD
Shares Outstanding 69,830,000
Codexis Inc specializes in discovering, developing, and selling enzymes and proteins for various applications. With a focus on biocatalysts, the company offers products and services that enhance the efficiency and productivity of manufacturing processes, particularly in the pharmaceutical sector. Codexis is known for its CodeEvolver technology platform, which aids in developing advanced biocatalysts. Additionally, it collaborates with entities like Nestlé Health Science on specific health treatments. Based in Redwood City, California, Codexis markets its innovations primarily in the United States and Europe.

CDXS Articles

These five stocks that Cathie Wood's ARK funds own millions of shares of are perfect for aggressive investors who look to get share count leverage on companies that have sizable upside potential.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including AstraZeneca, Bumble, McDonald’s and Microsoft.
The top analyst upgrades, downgrades and other research calls from Wednesday include ADP, Broadcom, Vale, VMware, Walgreens and Zebra Technologies.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Abercrombie & Fitch, Altria, Anthem, United Continental, Blackstone and AMAG Pharmaceuticals.
With the markets at or near record highs, the volume of insider selling has reached some of the highest levels this year.
Shares of KiOR slipped to an all-time low of $0.60 a share Tuesday after it filed its annual report with the U.S. Securities and Exchange Commission, a report in which it raised doubts that it could...
August 9, 2013: U.S. equity markets opened lower this morning and bounced around below the break-even line most of the day. The day’s biggest economic news came from China, where the CPI rose 2.7%...
U.S. equity markets opened lower this morning, kicking off a gradual decline that lasted all day. Profit-taking and a lower-than-expected reading on consumer sentiment in the U.S. get the blame. In...
ThinkstockThe U.S. Environmental Protection Agency (EPA) yesterday proposed new rules and percentage standards for 2013 biofuel consumption. The agency wants U.S. drivers to use 16.55 billion gallons...
Any tax legislation worth the name carries with it a host of hangers on that represent special gifts to special interests. The American Taxpayer Relief Act of 2012 is no different. Here is a rundown...
The three major US stock indexes opened lower this morning following more data from China. Both export and import data fell short, weighing on most Asian markets (more coverage here). There was...
The three major US stock indexes opened mixed this morning following a wealth of data on the Chinese economy. The short version is that the economy is slowing so much and inflation is so low that the...
Chemical and biofuels maker Gevo Inc. (NASDAQ: GEVO) announced this morning that it “intends to offer and sell, subject to market and other conditions, shares of its common stock and convertible...
Enzyme commercialization company Verenium Corp. (NASDAQ: VRNM) has announced the sale of several of its assets to Dutch firm DSM Food Specialties B.V., a business group of Royal DSM. The sale...
In 2007, the U.S. Congress established mandates for the amount of cellulosic ethanol and other biofuels to be used in the nation’s transportation fuel supply. Cellulosic ethanol and fuels based on...